Safety, tolerability, pharmacokinetic and pharmacodynamic profiles of edoxaban in healthy post-menopausal or surgically sterile females, and healthy elderly males

Trial Profile

Safety, tolerability, pharmacokinetic and pharmacodynamic profiles of edoxaban in healthy post-menopausal or surgically sterile females, and healthy elderly males

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Sep 2011

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Embolism; Stroke; Venous thromboembolism
  • Focus Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 13 Sep 2011 Planned number of patients changed from 24 to NULL.
    • 13 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top